Why Memorial Sloan-Kettering?
My decision to go to the Memorial Sloan-Kettering was the result of a number of factors. In part, I was guided by a sense of where I would feel most comfortable. It was easier to imagine three months of intense treatment in New York City, where I grew up and where my parents still lived, than 18 months of chemotherapy in Boston. A consultation with a senior physician at Harvard helped nudge me further towards New York and Memorial Sloan-Kettering. While careful not to say anything negative about his colleagues in Boston, he had nothing but high praise for the reputations of both Memorial Sloan-Kettering, in general, and Dr. Lisa DeAngelis, Chairman of the Department of Neurology and a neuro-oncologist with extensive experience in the care of patients with brain tumors, in particular. Finally, I spoke with both Dr. DeAngelis and the Boston doctor. As time was of the essence, I was forced to rely on first impressions. Unfortunately, there was something a bit cavalier, or patronizing, in
